The legal library gives you easy access to the FTC’s case information and other official legal, policy, and guidance documents.
20251045: AlpInvest Secondaries Fund VIII C.V.; Hidden Harbor Capital Partners Continuation Fund L.P.
20251054: CSW Industrials, Inc.; Aspen Manufacturing, LLC
20251044: AlpInvest Secondaries Fund VIII C.V.; HH-Dayco Parent, LP
HSR Rules
20251015: BIP Volt Blocker L.L.C.; Sun Communities, Inc.
20251006: Averill Fund, Ltd.; Benitec Biopharma Inc.
20251013: Ares Corporate Opportunities Fund VI, L.P.; Epika Fleet Services, Inc.
Leadership Calendar: Commissioner Melissa Holyoak - April 2025
Leadership Calendar: Commissioner Mark R. Meador - April 2025
20251002: Quartz Fibre pvt Ltd.; Owens Corning
2503007 Informal Interpretation
2503003 Informal Interpretation
2503006 Informal Interpretation
20251008: AbbVie Inc.; Gubra A/S
Xlear, Inc., U.S. v.
In October 2021, the FTC sued Xlear, Inc., a Utah-based company, for violating the COVID-19 Consumer Protection Act, alleging that it falsely pitched its saline nasal sprays as an effective way to prevent and treat COVID-19. DOJ filed the complaint on the FTC’s behalf. In March 2025, the DOJ agreed to dismiss the case with prejudice.